1. Jing Guo#,Chuzhong Li#,Qiuyue Fang,Yulou Liu,Dawei Wang,Yiyuan Chen,Weiyan Xie*,Yazhuo Zhang*.The SF3B1 R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1.Journal Of Experimental & Clinical Cancer Research.2022.41(1).26.SCI |
2. Jiwei Bai#, Jianxin Shi#, Chuzhong Li #, Shuai Wang#, Tongwu Zhang , Xing Hua, Bin Zhu , Hela Koka, Ho-Hsiang Wu , Lei Song, Difei Wang, Mingyi Wang , Weiyin Zhou,Bari J. Ballew, Bin Zhu, Belynda Hicks , Lisa Mirabello, Dilys M. Parry, Yixuan Zhai, Mingxuan Li, Jiang Du, Junmei Wang, Shuheng Zhang, .Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival.nature communications.2021.12(1).757.SCI |
3. Chuzhong Li#,Weiyan Xie#, Jared S. Rosenblum,Jianyu Zhou, Jing Guo, Yazhou Miao, Yutao Shen, Hongyun Wang, Lei Gong, Mingxuan Li,Sida Zhao, Sen Cheng, Haibo Zhu,Tao Jiang, Shiying Ling, Fei Wang, Hongwei Zhang,Zhengping Zhuang*, Yazhuo Zhang*.Somatic SF3B1 hotspot mutation in prolactinomas .Nature Communications.2021.11(1).2506.SCI |
4. Mingxuan Li,Yutao Shen,Yujia Xiong ,Shuai Wang,Chuzhong Li ,Jiwei Bai *,Yazhuo Zhang *.Loss of SMARCB1 promotes autophagy and facilitates tumour progression in chordoma by transcriptionally activating ATG5.Cell Proliferation.2021.54(12).13136.SCI |
5. Jiwei Bai,Mingxuan Li,Yujia Xiong,Yutao Shen,Chunhui Liu, Peng Zhao, Lei Cao,Songbai Gui,Chuzhong Li*, Yazhuo Zhang*.Proteomics Analysis Identified ASNS as a Novel Biomarker for Predicting Recurrence of Skull Base Chordoma.frontiers in oncology.2021.11.698497.SCI |
6. Song G, Qiu J, Li C, Li J, Gui S, Zhu H, Zhang Y*.Alterations of regional homogeneity and functional connectivity in pituitary adenoma patients with visual impairment.Scientific Reports.2017.7(1).-.SCI |
7. Wang J, Liu Q, Gao H, Wan D, Li C, Li Z, Zhang Y*.EGFL7 participates in regulating biological behavior of growth hormone-secreting pituitary adenomas via Notch2/DLL3 signaling pathway.Tumour Biol.2017.39 (7).-.SCI |
8. Wang J, Liu Q, Gao H, Wan D, Li C, Li Z, Zhang Y*.EGFL7 participates in regulating biological behavior of growth hormone-secreting pituitary adenomas via Notch2/DLL3 signaling pathway.Tumour Biol.2017.39 (7).-.SCI |
9. Weiyan Xie#,Chunhui Liu,Dan Wu, Zhenye Li, Chuzhong Li, and Yazhuo Zhang*.Phosphorylation of kinase insert domain receptor by cyclindependent kinase 5 at serine 229 is associated with invasive behavior and poor prognosis in prolactin pituitary adenomas.Oncotarget.2016.7.50883-50894.SCI |
10. YOUTU WU#, JIWEI BAI, LINCHUAN HONG, CHUNHUI LIU, SHENGYUAN YU, GUOQIANG YU and YAZHUO ZHANG*.Low expression of secreted frizzled.related protein 2 and nuclear accumulation of β.catenin in aggressive nonfunctioning pituitary adenoma.ONCOLOGY REPORTS.2016.12.199-206.SCI |
11. Youtu Wu#, Chunhui Liu, Shengyuan Yu, Hua Gao, Zhenye Li, Chuzhong Li and Yazhuo Zhang*.Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas.ONCOLOGY REPORTS.2016.35.2991-2999.SCI |
12. Chunhui Liu#, Hua Gao#, Lei Cao, Songbai Gui, Qian Liu, Chuzhong Li, Dan Li, Lei Gong, and Yazhuo Zhang*.The Role of FSCN1 in Migration and Invasion of Pituitary Adenomas.Mol Cell Endocrinol..2016.419.217-24.SCI |
13. Hua Gao, Fei Wang, Xiaolei Lan, Chuzhong Li, Jie Feng, Jiwei Bai, Lei Cao, Songbai Gui,Lichuan Hong and Yazhuo Zhang*.Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas. .BMC TUMOR.2015.15(1).272.SCI |
14. Wu Y, Bai J, Li Z, Wang F, Cao L, Liu C, Yu S, Yu G, Zhang Y*.Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenoma.Pituitary.2015.18(3).335-42.SCI |
15. Li Z, Liu Q, Li C, Zong X, Bai J, Wu Y, Lan X, Yu G, Zhang Y*.The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas.molecular and cellular endocrinology.2015.402.64-71.SCI |
16. Xie W, Wang H, He Y, Li D, Gong L, Zhang Y*.CDK5 and its activator P35 in normal pituitary and in pituitary adenomas: relationship to VEGF expression.Int J Biol Sci.2014.10(2).192-199. .SCI |
17. Cao L, Gao H, Gui S, Bai G, Lu R, Wang F, Zhang Y*.Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models.J Neurooncol.2014.116(3).523-531.SCI |
18. Hong L, Wu Y, Feng J, Yu S, Li C, Wu Y, Li Z, Cao L, Wang F, Zhang Y*.Overexpression of the cell adhesion molecule claudin-9 is associated with invasion in pituitary oncocytomas.human pathology.2014.45(12).2423-2429.SCI |
19. Zhenye L, Chuzhong L, Youtu W, Xiaolei L, Lei C, Lichuan H, Hongyun W, Yonggang W, Fei W, Yazhuo Z*.The expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas.journal of translational medicine.2014.12.71.SCI |
20. 姜之全,桂松柏,张亚卓*.Analysis of differential gene expression in plurihormonal pituitary adenomas using bead-based fiber-optic arrays.J Neurooncol.2012.108(3).341-348.SCI |
21. 张亚卓 .建立转化医学平台、促进神经外科人才培养 .中华神经外科杂志.2010.26(11).961-962.核心期刊 |
22. 裴傲; 张亚卓*; 宗绪毅; 王新生; 赵澎; 宋明;.内镜经鼻蝶入路手术治疗大型垂体腺瘤. 中国神经肿瘤杂志.2009.7(1).22-24. |
23. 刘方军; 张亚卓; 赵澎; 张永力; 孙玉明; 周忠清; 王计强; 石祥恩;.颅内血管外膜细胞瘤的临床诊治6例分析及文献复习 . 中国神经肿瘤杂志.2009.7(2).118-121. |
24. 李储忠; 赵澎; 宗绪毅; 桂松柏; 刘方军; 张亚卓*.单鼻孔内镜下经蝶、扩大经蝶入路肿瘤切除术术中、术后出血原因分析及对策 .中国神经肿瘤杂志 .2009.7(1).33-36. |
25. 李储忠; 张亚卓*.神经内镜应用进展 .中国神经精神疾病杂志.2009.35(2).67—68. |
26. 桂松柏; 张亚卓*; 王新生; 宗绪毅; 赵澎;.内镜颅底手术后颅内感染的综合治疗1例报告 .中国神经肿瘤杂志 .2009.7(1).37-38. |
27. 宋明1, 张亚卓2*.内镜技术在中枢神经系统肿瘤治疗中的应用.中国神经肿瘤杂志.2009.7(1).1-5. |
28. 赵澎1, 桂松柏1, 李储忠1, 宋明2, 裴傲3, 王新生1, 宗绪毅1, 张亚卓*.神经内镜治疗脑室内肿瘤20 例临床经验.中国神经肿瘤杂志.2009.7(1).7-13. |
29. 桂松柏,张亚卓*孙梅珍.氧化损伤星形胶质细胞与骨髓基质细胞共培养的实验研究 .中华神经医学杂志 .2008.7(3).267-272. |
30. 赵澎,张亚卓*.Reversion of nultidrug resistance in human glioma by RNA interference .Neurological Research.2008.30.562~566. |
31. 严耀华,张亚卓*.三脑室底造瘘中的心率变化.中华神经外科杂志.2008.24(3).193-195. |
32. 宋明,张亚卓*,王新生,宗绪毅.内镜下经鼻入路显露视神经和眼眶的解剖研究.中国内镜杂志.2008.14(4).357-360. |
33. 刘方军,张亚卓*,桂松柏,孙泽林.F90对胶质母细胞瘤的作用及机制研究.中国微侵袭神经外科杂志.2008.13(5).220-222. |